Literature DB >> 12623045

Magnetic resonance spectroscopic abnormalities in sporadic and variant Creutzfeldt-Jakob disease.

H G Pandya1, S C Coley, I D Wilkinson, P D Griffiths.   

Abstract

AIM: To study the proton MR spectroscopic findings in Creutzfeldt-Jakob disease (CJD) (sporadic and variant).
MATERIALS AND METHODS: MR imaging and proton MR spectra were acquired in two patients with sporadic CJD (biopsy proven) and one patient with variant CJD.
RESULTS: The two patients with sporadic CJD demonstrated MR signal change within the basal ganglia and thalami and reduced N-acetylaspartate (NAA):creatine ratios. The patient with variant CJD showed characteristic signal change within the pulvinar of the thalami and a markedly reduced N-acetylaspartate:creatine ratio.
CONCLUSION: All three patients with CJD demonstrated evidence of reduced N-acetylaspartate: creatine ratios on MR spectroscopy. These changes imply that neuronal loss and/or dysfunction is a consistent finding in established CJD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12623045     DOI: 10.1053/crad.2002.1080

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  11 in total

1.  MRS in early and presymptomatic carriers of a novel octapeptide repeat insertion in the prion protein gene.

Authors:  Eric M McDade; Bradley F Boeve; Julie A Fields; Neeraj Kumar; Rosa Rademakers; Matt C Baker; Bsc David S Knopman; Ronald C Petersen; Clifford R Jack; Kejal Kantarci
Journal:  J Neuroimaging       Date:  2012-05-21       Impact factor: 2.486

2.  Combined diffusion imaging and MR spectroscopy in the diagnosis of human prion diseases.

Authors:  Damien Galanaud; S Haik; M G Linguraru; J-P Ranjeva; B Faucheux; E Kaphan; N Ayache; J Chiras; P Cozzone; D Dormont; J-P Brandel
Journal:  AJNR Am J Neuroradiol       Date:  2010-04-29       Impact factor: 3.825

3.  Diffusion-weighted imaging and magnetic resonance spectroscopy of sporadic Creutzfeldt-Jakob disease: correlation with clinical course.

Authors:  Jae Hyoung Kim; Byung Se Choi; Cheolkyu Jung; YoungHee Chang; SangYun Kim
Journal:  Neuroradiology       Date:  2011-01-11       Impact factor: 2.804

4.  Neuroimaging in human prion disease: Searching in the mist.

Authors:  Panayotis Ioannides; Dimitris Karacostas
Journal:  World J Radiol       Date:  2009-12-31

5.  Short TE quantitative proton magnetic resonance spectroscopy in variant Creutzfeldt-Jakob disease.

Authors:  R J Cordery; D MacManus; A Godbolt; M N Rossor; A D Waldman
Journal:  Eur Radiol       Date:  2006-01-12       Impact factor: 5.315

6.  In Vivo Longitudinal (1)H MRS Study of Transgenic Mouse Models of Prion Disease in the Hippocampus and Cerebellum at 14.1 T.

Authors:  Cristina Cudalbu; Melanie Craveiro; Vladimir Mlynárik; Juliane Bremer; Adriano Aguzzi; Rolf Gruetter
Journal:  Neurochem Res       Date:  2015-07-23       Impact factor: 3.996

7.  Familial Creutzfeldt-Jakob disease with a V180I mutation: comparative analysis with pathological findings and diffusion-weighted images.

Authors:  Kazuo Mutsukura; Katsuya Satoh; Susumu Shirabe; Itsuro Tomita; Takayasu Fukutome; Minoru Morikawa; Masachika Iseki; Kensuke Sasaki; Yusei Shiaga; Tetsuyuki Kitamoto; Katsumi Eguchi
Journal:  Dement Geriatr Cogn Disord       Date:  2009-12-30       Impact factor: 2.959

Review 8.  Neuroimaging biomarkers of neurodegenerative diseases and dementia.

Authors:  Shannon L Risacher; Andrew J Saykin
Journal:  Semin Neurol       Date:  2013-11-14       Impact factor: 3.420

Review 9.  Neuroimaging findings in human prion disease.

Authors:  R G Macfarlane; S J Wroe; J Collinge; T A Yousry; H R Jäger
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-11-29       Impact factor: 10.154

10.  Magnetic resonance diagnostic markers in clinically sporadic prion disease: a combined brain magnetic resonance imaging and spectroscopy study.

Authors:  Raffaele Lodi; Piero Parchi; Caterina Tonon; David Manners; Sabina Capellari; Rosaria Strammiello; Rita Rinaldi; Claudia Testa; Emil Malucelli; Barbara Mostacci; Giovanni Rizzo; Giulia Pierangeli; Pietro Cortelli; Pasquale Montagna; Bruno Barbiroli
Journal:  Brain       Date:  2009-09-15       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.